The changing face of infectious diseases in the UK
Amber and Eldrian discuss the UK's infectious disease landscape in 2025.
From research on plastics to malaria: the Great Exhibition Road Festival returns
Fantastic plastic and CRISPR critters – Felix recaps a selection of scientific endeavours on display at this year’s Great Exhibition Road Festival.
Imperial team test “Mother Nature’s” mental health solution
Prof Edalat’s team combines attachment theory, AI chatbots, and personalised avatars to teach people how to find humour in almost any situation.
CRISPR therapy saves infant with rare metabolic disorder
CRISPR-based gene editing therapy has been used for the first time to treat CPS1 deficiency, which promises a new era for precision medicine.
A blast from the past, using Felix’s AI déjà vu tool!
We test a novel semantic search tool to trawl the archives
Microbiology Society Conference: Driving Innovation Against Antimicrobial Resistance
Imperial researchers presented their work at this year’s conference in Liverpool
An Alchemist’s Dream
Alice Choubry explores the work of alchemists, their lasting impact on science, and how scientists transmuted gold in particle accelerators.
This Week In Science (14/03/2025)
Felix's weekly digest of Science news
The human antibiotic factory
Recent publications have shed light on the human proteasome’s role in natural antibiotic production.
This Week In Science (07/03/2025)
Felix's weekly digest of Science news
The state of the European healthcare industry
Felix sat down with Imperial graduate and life sciences consultant Sayak Bhattacharya to discuss the state of the pharmaceutical industry.
Ozempic: more than a weight-loss drug
Studies suggest that Ozempic has been found to reduce alcohol cravings, cigarette smoking, and obesity-related cancers.